References
- Jailobaeva K, Falconer J, Loffreda G, Arakelyan S, Witter S, Ager A. An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries. Global Health. 2021;17:68. doi:10.1186/s12992-021-00713-4
- Creating an integrated approach to noncommunicable diseases: through focus on patient-centered, sustainable, scalable local solutions. Whitepaper. Available from: https://protect-us.mimecast.com/s/EdQfCM8E9pHxgZMOMI9SERc?domain=newsroom.viatris.com. Accessed April 18, 2023.
- United Nations. General Assembly. Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases Time to deliver: accelerating our response to address non-communicable diseases for the health and well-being of present and future generations. Available from: https://digitallibrary.un.org/record/710899. Accessed October 3, 2018.
- World Health Organization. 2021 World Health Statistics. Available from: https://apps.who.int/iris/bitstream/handle/10665/342703/9789240027053-eng.pdf. Accessed June 4, 2022.
- Bharatan T, Devi R, Huang P-H, et al. A methodology for mapping the patient journey for noncommunicable diseases in low- and middle-income countries. J Healthc Leadersh. 2021;13:35–46. doi:10.2147/JHL.S288966
- World Health Organization. SDG target 3.4 Non-communicable diseases and mental health. Available from: https://www.who.int/data/gho/data/themes/topics/sdg-target-3_4-noncommunicable-diseases-and-mental-health. Accessed June 04, 2022.
- Chan JCN, Lim LL, Wareham NJ, et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet. 2020;396:2019–2082.
- World health organization. Chronic respiratory diseases. Key facts. Available from: https://www.who.int/health-topics/chronic-respiratory-diseases#tab=tab_1. Accessed October 25, 2021.
- Checkley W, Ghannem H, Irazola V, et al. Management of NCD in low- and middle-income countries. Glob Heart. 2014;9:431–443. doi:10.1016/j.gheart.2014.11.003
- Hategeka C, Adu P, Desloge A, et al. Implementation research on noncommunicable disease prevention and control interventions in low- and middle-income countries: a systematic review. PLoS Med. 2022;19(7):e1004055. doi:10.1371/journal.pmed.1004055
- Collins T, Akselrod S, Berlina D, et al. Unleashing implementation research to accelerate national noncommunicable disease responses. Global Health. 2022;18:6. doi:10.1186/s12992-021-00790-5
- Jackson-Morris AM, Mutungi G, Maree E, Waqanivalu T, Marten R, Nugent R. ‘Implementability’ matters: using implementation research steps to guide and support non-communicable disease national planning in low-income and middle-income countries. BMJ Glob Health. 2022;7(4):e008275. doi:10.1136/bmjgh-2021-008275
- Peters DH, Tran NT, Adam T. Implementation research in health: a practical guide. Available from: https://apps.who.int/iris/bitstream/handle/10665/91758/9789241506212_eng.pdf. Accessed February 08, 2023.
- Ausmed. Closing the Theory-practice gap: is it possible? Available from: https://www.ausmed.com/cpd/articles/close-theory-practice-gap. Accessed October 06, 2021.
- Charani E, Abimbola S, Pai M, et al. Funders: the missing link in equitable global health research? PLOS Glob Public Health. 2022;2(6):e0000583. doi:10.1371/journal.pgph.0000583
- Breda J, Allen LN, Tibet B, et al. Estimating the impact of achieving Turkey’s non-communicable disease policy targets: a macro-simulation modelling study. Lancet Reg Health Eur. 2021;1:100018. doi:10.1016/j.lanepe.2020.100018
- Castillo-Carandang NT, Buenaventura RD, Chia Y-C, et al. Moving towards optimized noncommunicable disease management in the ASEAN Region: recommendations from a review and multidisciplinary expert panel. Risk Manag Healthc Policy. 2020;15(13):803–819. doi:10.2147/RMHP.S256165
- GBD 2017 Diet Collaborators. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;393(10184):1958–1972. doi:10.1016/S0140-6736(19)30041-8
- Budreviciute A, Damiati S, Sabir DK, et al. Management and prevention strategies for non-communicable diseases (NCDs) and their risk factors. Front Public Health. 2020;8. doi:10.3389/fpubh.2020.574111
- Miranda JJ, Kinra S, Casas JP, Davey Smith G, Ebrahim S. Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health. 2008;13:1225–1234. doi:10.1111/j.1365-3156.2008.02116.x
- Glasgow RE, Battaglia C, McCreight M, Ayele RA, Rabin BA. Making implementation science more rapid: use of the RE-AIM framework for mid-course adaptations across five health services research projects in the veterans health administration. Front Public Health. 2020;27(8):194. doi:10.3389/fpubh.2020.00194
- World health organization. Noncommunicable diseases. Key facts. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases. Accessed October 6, 2021.
- Pakenham-Walsh N. Learning from one another to bridge the “know-do gap”. Br Med J. 2004;329:1189. doi:10.1136/bmj.329.7475.1189
- Global Alliance for Chronic Diseases. Dissemination & implementation. Available from: https://www.div12.org/implementation/overview/. Accessed October 21, 2021.
- Eccles MP, Mittman BS. Welcome to Implementation Science. Implementation Sci. 2006;1(1). doi:10.1186/1748-5908-1-1
- University of Washington. What is implementation science? Available from: https://impsciuw.org/implementation-science/learn/implementation-science-overview/. Accessed November 9, 2021.
- Bauer MS, Damschroder L, Hagedorn H, Smith J, Kilbourne AM. An introduction to implementation science for the non-specialist. BMC Psychol. 2015;3:32. doi:10.1186/s40359-015-0089-9
- Lim LL, Lau ESH, Kong APS, et al. Aspects of multicomponent integrated care promote sustained improvement in surrogate clinical outcomes: a systematic review and meta-analysis. Diabetes Care. 2018;41:1312–1320. doi:10.2337/dc17-2010
- Owolabi MO, Yaria JO, Daivadanam M, et al. Gaps in guidelines for the management of diabetes in low- and middle-income versus high-income countries-a systematic review. Diabetes Care. 2018;41:1097–1105. doi:10.2337/dc17-1795
- Mitchell SA, Chambers DA. Leveraging implementation science to improve cancer care delivery and patient outcomes. J Oncol Pract. 2017;8:523–529. doi:10.1200/JOP.2017.024729
- Dineen TE, Bean C, Jung ME. Implementation of a diabetes prevention program within two community sites: a qualitative assessment. Implement Sci Commun. 2022;3:11. doi:10.1186/s43058-022-00258-6
- Gotham HJ, Cummings JR, Dolce JN, et al. Applying implementation science in mental health services: technical assistance cases from the Mental Health Technology Transfer Center (MHTTC) network. Gen Hosp Psychiatry. 2022;75:1–9. doi:10.1016/j.genhosppsych.2022.01.004
- Musinguzi G, Wanyenze RK, Ndejjo R, et al. An implementation science study to enhance cardiovascular disease prevention in Mukono and Buikwe districts in Uganda: a stepped-wedge design. BMC Health Serv Res. 2019;19:253. doi:10.1186/s12913-019-4095-0
- King A. The heart of a woman: addressing the gender gap in cardiovascular disease. Nat Rev Cardiol. 2011;8:239–240. doi:10.1038/nrcardio.2011.49
- Aifah A, Iwelunmor J, Akwanalo C, et al. The Kathmandu declaration on global CVD/hypertension research and implementation science: a framework to advance implementation research for cardiovascular and other noncommunicable diseases in low- and middle-income countries. Glob Heart. 2019;14:103–107. doi:10.1016/j.gheart.2019.05.006
- World health organization. Cardiovascular diseases. Key facts. Available from: https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1. Accessed October 25, 2021.
- Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021. doi:10.1016/j.jacc.2020.11.010
- NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–980. doi:10.1016/S0140-6736(21)01330-1
- Kandula NR, Tirodkar MA, Lauderdale DS, Khurana NR, Makoul G, Baker DW. Knowledge gaps and misconceptions about coronary heart disease among U.S. South Asians. Am J Prev Med. 2010;38:439–442. doi:10.1016/j.amepre.2009.12.034
- Chow CK, Rodgers A. Lost in translation: the gap between what we know and what we do about cardiovascular disease. Med J Aust. 2016;204:291–292. doi:10.5694/mja16.00190
- Pearson TA, Peters TD. The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient. Am J Cardiol. 1997;80:45H–52H. doi:10.1016/S0002-9149(97)00820-5
- World health organization. SCORE for health data package. Available from: https://www.who.int/data/data-collection-tools/score. Accessed July 23, 2022.
- Štulc T, Lánská V, Šnejdrlová M, Vrablík M, Prusíková M, Češka R. A comprehensive guidelines-based approach reduces cardiovascular risk in everyday practice: the VARO study. Arch Med Sci. 2017;13:705–710. doi:10.5114/aoms.2016.64865
- McClellan M, Brown N, Califf RM, Warner JJ. Call to action: urgent challenges in cardiovascular disease: a presidential advisory from the American Heart Association. Circulation. 2019;139:e44–e54. doi:10.1161/CIR.0000000000000652
- World health organization. Chronic obstructive pulmonary disease. Key facts. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed January 4, 2022.
- The global asthma report 2018. Auckland, New Zealand: Global Asthma Network; 2018. Available from: http://globalasthmareport.org/2018/index.html. Accessed February 17, 2022.
- GBD Chronic Respiratory. Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8:585–596. doi:10.1016/S2213-2600(20)30105-3
- Labaki WW, Han MK. Chronic respiratory diseases: a global view. Lancet Respir Med. 2020;8:531–533. doi:10.1016/S2213-2600(20)30157-0
- Labaki WW, Han MK. Improving detection of early chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2018;15:S243–S248. doi:10.1513/AnnalsATS.201808-529MG
- Laniado-Laborín R. Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century. Int J Environ Res Public Health. 2009;6:209–224. doi:10.3390/ijerph6010209
- Balmes JR, Eisen EA. Household air pollution and chronic obstructive pulmonary disease. “a riddle, wrapped in a mystery, inside an Enigma”. Am J Respir Crit Care Med. 2018;197:547–549. doi:10.1164/rccm.201801-0033ED
- Perera F. Pollution from fossil-fuel combustion is the leading environmental threat to global pediatric health and equity: solutions exist. Int J Environ Res Public Health. 2017;15:16. doi:10.3390/ijerph15010016
- Sidhaye VK, Nishida K, Martinez FJ. Precision medicine in COPD: where are we and where do we need to go? Eur Respir Rev. 2018;27:180022. doi:10.1183/16000617.0022-2018
- Boulet LP, Bourbeau J, Skomro R, Gupta S. Major care gaps in asthma, sleep and chronic obstructive pulmonary disease: a road map for knowledge translation. Can Respir J. 2013;20:265–269. doi:10.1155/2013/496923
- Nakken N, Janssen DJA, van den Bogaart EHA, et al. Knowledge gaps in patients with COPD and their proxies. BMC Pulm Med. 2017;17:136. doi:10.1186/s12890-017-0481-8
- Jin L, An W, Li Z, Jiang L, Chen C. Pulmonary rehabilitation training for improving pulmonary function and exercise tolerance in patients with stable chronic obstructive pulmonary disease. Am J Transl Res. 2021;13:8330–8336.
- Sahasrabudhe SD, Orme MW, Jones AV, Tillu G, Salvi SS, Singh SJ. Potential for integrating yoga within pulmonary rehabilitation and recommendations of reporting framework. BMJ Open Respir Res. 2021;8:e000966. doi:10.1136/bmjresp-2021-000966
- Pratiti R, Vadala D, Kalynych Z, Sud P. Health effects of household air pollution related to biomass cook stoves in resource limited countries and its mitigation by improved cookstoves. Environ Res. 2020;186:109574. doi:10.1016/j.envres.2020.109574
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi:10.3322/caac.21660
- World health organization. Cancer. Available from: https://www.who.int/health-topics/cancer#tab=tab_1. Accessed November 9, 2021.
- Elmore LW, Greer SF, Daniels EC, et al. Blueprint for cancer research: critical gaps and opportunities. CA Cancer J Clin. 2021;71:107–139. doi:10.3322/caac.21652
- Eccles SA, Aboagye EO, Ali S, et al. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res. 2013;15:R92. doi:10.1186/bcr3493
- Thompson A, Brennan K, Cox A, et al. Evaluation of the current knowledge limitations in breast cancer research: a gap analysis. Breast Cancer Res. 2008;10:R26. doi:10.1186/bcr1983
- Lee Smith J, Hall IJ. Advancing health equity in cancer survivorship: opportunities for public health. Am J Prev Med. 2015;49:S477–S482. doi:10.1016/j.amepre.2015.08.008
- International Diabetes Federation. Type 2 diabetes. Available from: https://idf.org/aboutdiabetes/type-2-diabetes.html. Accessed November 9, 2021.
- International Diabetes Federation. IDF diabetes atlas. Brussels, Belgium: International Diabetes Federation; 2019. Available from: https://diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9e-final-web.pdf. Accessed January 06, 2022.
- International Diabetes Federation Diabetes Atlas. Diabetes around the world in 2021. Available from: https://diabetesatlas.org/. Accessed November 09, 2021.
- Dunlay SM, Givertz MM, Aguilar D, et al. Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation. 2019;140:e294–e324. doi:10.1161/CIR.0000000000000691
- Steenblock C, Schwarz PEH, Ludwig B, et al. COVID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol. 2021;9:786–798. doi:10.1016/S2213-8587(21)00244-8
- Karachaliou F, Simatos G, Simatou A. The challenges in the development of diabetes prevention and care models in low-income settings. Front Endocrinol. 2020;11:518. doi:10.3389/fendo.2020.00518
- Shivashankar R, Kirk K, Kim WC, et al. Quality of diabetes care in low- and middle-income Asian and Middle Eastern countries (1993–2012): 20-year systematic review. Diabetes Res Clin Pract. 2015;107:203–223. doi:10.1016/j.diabres.2014.11.004
- Davies MJ, D’Alessio DA, Fradkin J, et al. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2018;61:2461–2498. doi:10.1007/s00125-018-4729-5
- American Diabetes Association. Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes. 2015;33:97–111. doi:10.2337/diaclin.33.2.97
- Magliano DJ, Chen L, Carstensen B, et al. Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data. Lancet Diabetes Endocrinol. 2022;10:112–119. doi:10.1016/S2213-8587(21)00327-2
- Ross JAD, Barron E, McGough B, et al. Uptake and impact of the English National Health Service digital diabetes prevention programme: observational study. BMJ Open Diabetes Res Care. 2022;10:e002736. doi:10.1136/bmjdrc-2021-002736
- Binns-Hall O, Selvarajah D, Sanger D, Walker J, Scott A, Tesfaye S. One-stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot. Diabet Med. 2018;35:887–894. doi:10.1111/dme.13630
- Hyman SE. The unconscionable gap between what we know and what we do. Sci Transl Med. 2014;6:253cm9. doi:10.1126/scitranslmed.3010312
- World Health Organization. World Health Report 2001. Mental health: new understanding, new hope. Geneva, Switzerland: World Health Organization; 2001. Available from: https://apps.who.int/iris/handle/10665/42390. Accessed March 05, 2023.
- James SL, Abate D, Abate KH. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–1858.
- IHME. New Global Burden of Disease analyses show depression and anxiety among the top causes of health loss worldwide, and a significant increase due to the COVID-19 pandemic. Available from: http://www.healthdata.org/acting-data/new-ihme-analyses-show-depression-and-anxiety-among-top-causes-health-burden-worldwide. Accessed November 23, 2021.
- Fisher EB, Chan JC, Nan H, Sartorius N, Oldenburg B. Co-occurrence of diabetes and depression: conceptual considerations for an emerging global health challenge. J Affect Disord. 2012;142:S56–S66. doi:10.1016/S0165-0327(12)70009-5
- Qin X, Hsieh CR. Understanding and addressing the treatment gap in mental healthcare: economic perspectives and evidence from China. Inquiry. 2020;57. doi:10.1177/0046958020950566
- Kohn R, Saxena S, Levav I, Saraceno B. The treatment gap in mental health care. Bull World Health Organ. 2004;82:858–866.
- Van Ginneken N, Tharyan P, Lewin S, et al. Non-specialist health worker interventions for the care of mental, neurological and substance-abuse disorders in low- and middle-income countries. Cochrane Database Syst Rev. 2013;11. doi:10.1002/14651858.CD009149.pub2
- Corrigan P. How stigma interferes with mental health care. Am Psychol. 2004;59:614–625. doi:10.1037/0003-066X.59.7.614
- Miller CJ, Smith SN, Pugatch M. Experimental and quasi-experimental designs in implementation research. Psychiatry Res. 2020;283:112452.
- Allen NL, Nicholson DB, Yeung TB, Goiana-da-Silva F. Implementation of non-communicable disease policies: a geopolitical analysis of 151 countries. Lancet Glob Health. 2020;8:e50–e58. doi:10.1016/S2214-109X(19)30446-2
- Lopez MA, Basco MA. Effectiveness of cognitive behavioral therapy in public mental health: comparison to treatment as usual for treatment-resistant depression. Adm Policy Ment Health. 2015;42:87–98. doi:10.1007/s10488-014-0546-4
- World Health Organization. WHO package of essential noncommunicable (PEN) disease interventions for primary health care; 2022.
- Collins D, Inglin L, Laatikainen T, et al. Implementing a package of noncommunicable disease interventions in the Republic of Moldova: two-year follow-up data. Prim Health Care Res Dev. 2020;21. doi:10.1017/S1463423620000420
- Schwarz D, Dhungana S, Kumar A, et al. An integrated intervention for chronic care management in rural Nepal: protocol of a type 2 hybrid effectiveness-implementation study. Trials. 2020;21:119. doi:10.1186/s13063-020-4063-3
- Pablos-Mendez A, Shademani R. Knowledge translation in global health. J Contin Educ Health Prof. 2006;26:81–86. doi:10.1002/chp.54
- World health organization. Bridging the “Know–Do” gap meeting on knowledge translation in global health. Available from: https://www.measureevaluation.org/resources/training/capacity-building-resources/high-impact-research-training-curricula/bridging-The-know-do-gap.pdf. Accessed October 6, 2021.
- World health organization. A guide to implementation research in the prevention and control of noncommunicable diseases. Available from: https://apps.who.int/iris/bitstream/handle/10665/252626/9789241511803-eng.pdf. Accessed January 05, 2023.
- NIH. Fogarty international center. Toolkit Part 1: implementation science methodologies and frameworks. Available from: https://www.fic.nih.gov/About/center-global-health-studies/neuroscience-implementation-toolkit/Pages/methodologies-frameworks.aspx. Accessed October 06, 2021.
- NIH. Fogarty international center. Toolkit part 2: participatory research models and building stakeholder relationships. Available from: https://www.fic.nih.gov/About/center-global-health-studies/neuroscience-implementation-toolkit/Pages/methodologies-frameworks.aspx. Accessed October 06, 2021.
- NIH. Fogarty international center. Toolkit part 3: dissemination strategies in evidence-based policy and practice. Available from: https://www.fic.nih.gov/About/center-global-health-studies/neuroscience-implementation-toolkit/Pages/methodologies-frameworks.aspx. Accessed October 06, 2021.
- Nilsen P. Making sense of implementation theories, models and frameworks. Implement Sci. 2015;10:53. doi:10.1186/s13012-015-0242-0
- McGinty EE, Eisenberg MD. Mental health treatment gap-the implementation problem as a research problem. JAMA Psychiatry. 2022;79(8):746. doi:10.1001/jamapsychiatry.2022.1468
- Breda J, Wickramasinghe K, Peters DH, et al. One size does not fit all: implementation of interventions for non-communicable diseases. BMJ. 2019;367. doi:10.1136/bmj.l6434
- Votova K, Laberge A-M, Grimshaw JM, Wilson B. Implementation science as a leadership capability to improve patient outcomes and value in healthcare. Healthc Manage Forum. 2019;32:307–312. doi:10.1177/0840470419867427
- United Nations. World population ageing 2019. highlights. Available from: https://www.un.org/en/development/desa/population/publications/pdf/ageing/.WorldPopulationAgeing2019-Highlights.pdf. Accessed January 06, 2022.
- Hillas G, Perlikos F, Tsiligianni I, Tzanakis N. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:95–109. doi:10.2147/COPD.S54473
- Ministry of Health and Family Welfare. National multisectoral action plan for prevention and control of common NCDS. Available from: https://main.mohfw.gov.in/sites/default/files/National%20Multisectoral%20Action%20Plan%20%28NMAP%29%20for%20Prevention%20and%20Control%20of%20Common%20NCDs%20%282017-22%29_1.pdf. Accessed June 06, 2022.
- Thamlikitkul V. Bridging the gap between knowledge and action for health: case studies. Bull World Health Organ. 2006;84:603–607. doi:10.2471/BLT.05.023622
- Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations. Circulation. 2016;133:2459–2502. doi:10.1161/CIRCULATIONAHA.116.022194
- Seshasai SR, Kaptoge S, Thompson A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364:829–841.
- Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580–591. doi:10.1056/NEJMoa0706245
- Jiao FF, Fung CSC, Wan EYF, et al. Five-year cost-effectiveness of the multidisciplinary risk assessment and management programme-diabetes mellitus (RAMP-DM). Diabetes Care. 2018;41:250–257. doi:10.2337/dc17-1149
- European Diabetes Forum. EUDF policy recommendations. European Diabetes Forum (eudf.org); 2022.
- World Health Organization. A guide to implementation research in the prevention and control of noncommunicable diseases. Geneva: World Health Organization; 2016. Available from: https://apps.who.int/iris/bitstream/handle/10665/252626/9789241511803-eng.pdf. Accessed March 05, 2023.
- Goyet S, Touch S, Ir P, et al. Gaps between research and public health priorities in low income countries: evidence from a systematic literature review focused on Cambodia. Implement Sc. 2015;10:1–2.